KalshiScience and Technology

When will Beam Therapeutics submit a BLA for Risto-cel?

Ristoglogene autogetemcel (risto-cel) - BLA

Ends Sep 1, 2026

Disclosure

18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.

Probability

before September7.5K VOL.
Yes 1%No 99%
1¢
before October9.4K VOL.
Yes 8%No 92%
8¢
before November2.1K VOL.
Yes 9%No 91%
9¢
before December706.5 VOL.
Yes 49%No 51%
49¢
before 202746.1 VOL.
Yes 56%No 44%
56¢

Rules Summary

If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.

Timeline and Payout

Opened: Mar 24, 2026, 2:00 PM
Closes: Sep 1, 2026, 2:00 PM
Pays out: 0.5 hours after close

Series KXNEWDRUGAPPBEAM · Event KXNEWDRUGAPPBEAM-RIST · Market KXNEWDRUGAPPBEAM-RIST-26SEP01